APLM: Receives Nasdaq Notice
Apollomics receives Nasdaq deficiency notice regarding minimum market value requirement and updates rights for Vebreltinib in Asia
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Apollomics receives Nasdaq deficiency notice regarding minimum market value requirement and updates rights for Vebreltinib in Asia